Overview

• Goldman Sachs analysts have identified several stocks with significant growth potential, despite current market uncertainties.
• Jefferies has upgraded a little-known biotech stock, predicting more than 100% upside.
• Despite recent struggles, analysts predict a near-term bounce for the oil market.
• Wall Street is awaiting key inflation data next week, seeking confirmation that the Federal Reserve's actions are complete.
• Bank of America suggests that certain underperforming stocks could surge as the year winds down.
• Luxury stocks are expected to maintain their value even as sales growth slows to pre-pandemic levels.